 | Study programme 2025-2026 | Français | |
| Etude des médicaments d'origine biologique | |||
Learning Activity |
| Code | Lecturer(s) | Associate Lecturer(s) | Subsitute Lecturer(s) et other(s) | Establishment |
|---|---|---|---|---|
| M-ANPH-080 |
|
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term |
|---|---|---|---|---|---|---|---|
| Français | Français | 20 | 0 | 0 | 0 | 0 | Q1 |
Content of Learning Activity
The first part of the lecture is dedicated to a general overview of biologicals drugs (BD) : nature (proteins, nucleic acids, stem cells, ..), preparation, characterization, production and quality control. Special emphasis will be given to analytical methods and biotechnologies used to study BD.
Second part of the lecture will focuse on the description of the different BD that are currently used in pharmacotherapy focusing on their target(s) in the human body.
Overview will include the following BD categories: antitumorals, immunomodulators, hormonal peptides, BD of cardiovascular system, antivirals, antiangiogenesis and vaccines.
For each BD, the mechanism of action, clinical use and adverse effects will be described.
Required Learning Resources/Tools
Powerpoint (available on Moodle)
Recommended Learning Resources/Tools
CBIP
Analytical characterization of biotherapeutics - Wiley ; 2017 ISBN: 978-1-119-05310-1
Directive 2001/83/EC, https://ec.europa.eu/health/documents/eudralex/vol-1_fr
Other Recommended Reading
Not applicable
Mode of delivery
- Face-to-face
Type of Teaching Activity/Activities
- Cours magistraux
Evaluations
The assessment methods of the Learning Activity (AA) are specified in the course description of the corresponding Educational Component (UE)
Location of learning activity
- Université de Mons - Mons
Location of assessment
- Université de Mons - Mons